You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Senvest Management | 0 | 1,302,272 | 0 | 1,302,272 | 1,302,272 | 3.72% |
| Richard Mashaal | 0 | 1,302,272 | 0 | 1,302,272 | 1,302,272 | 3.72% |
Follow Richard Mashaal's Rima Senvest Management
Page 1 of 7 – SEC Filing
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| | |
| SCHEDULE 13G/A | |
| Under the Securities Exchange Act of 1934 | |
| (Amendment No. 6)* | |
| Syneron Medical | |
| (Name of Issuer) | |
| Ordinary | |
| (Title of Class of Securities) | |
| M87245102 | |
| (CUSIP Number) | |
| April 3, | |
| (Date of Event Which Requires Filing of this Statement) | |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: | |
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
| (Page 1 of 7 Pages) | |
______________________________
*The remainder of
this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information
required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act“) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 2 of 7 – SEC Filing
| 1 | NAME OF REPORTING PERSON Senvest Management, LLC | |||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ¨ (b) ¨ | ||
| 3 | SEC USE ONLY | |||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER 0 | ||
| 6 | SHARED VOTING POWER 1,302,272** | |||
| 7 | SOLE DISPOSITIVE POWER 0 | |||
| 8 | SHARED DISPOSITIVE POWER 1,302,272** | |||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,302,272** | |||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ | ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.72%** | |||
| 12 | TYPE OF REPORTING PERSON OO, IA | |||
**Represents beneficial ownership as of April 3, 2017. As of
the date hereof, the Reporting Person no longer beneficially owns any Ordinary Shares.
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 3 of 7 – SEC Filing
| 1 | NAME OF REPORTING PERSON Richard Mashaal | |||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ¨ (b) ¨ | ||
| 3 | SEC USE ONLY | |||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Canada | |||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER 0 | ||
| 6 | SHARED VOTING POWER 1,302,272** | |||
| 7 | SOLE DISPOSITIVE POWER 0 | |||
| 8 | SHARED DISPOSITIVE POWER 1,302,272** | |||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,302,272** | |||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ | ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.72%** | |||
| 12 | TYPE OF REPORTING PERSON IN, HC | |||
**Represents beneficial ownership as of April 3, 2017. As of
the date hereof, the Reporting Person no longer beneficially owns any Ordinary Shares.
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 4 of 7 – SEC Filing
| Item 1(a). | Name of Issuer. |
| Syneron Medical Ltd. (the “Issuer“) |
| Item 1(b). | Address of Issuer’s Principal Executive Offices. |
| Industrial Zone Yokneam Illit 20692 Israel |
| Item 2(a). | Name of Person Filing. |
| This statement is filed by Senvest Management, LLC and Richard Mashaal. | |
| The reported securities are held in the accounts of Senvest Master Fund, LP, Senvest Israel Partners Master Fund, LP and Senvest Global (KY), LP (collectively, the “Investment Vehicles“). | |
| Senvest Management, LLC may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC’s position as investment manager of the Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Mr. Mashaal’s status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the Ordinary Shares reported herein. | |
| Item 2(b). | Address of Principal Business Office. |
| Senvest Management, LLC 540 Madison Avenue, 32nd Floor New York, New York 10022 | |
| Richard Mashaal c/o Senvest Management, LLC 540 Madison Avenue, 32nd Floor New York, New York 10022 | |
| Item 2(c). | Place of Organization. |
| Senvest Management, LLC – Delaware Richard Mashaal – Canada |
| Item 2(d). | Title of Class of Securities. |
| Ordinary Shares, par value NIS 0.01 per share |
| Item 2(e). | CUSIP Number. |
| M87245102 |
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 5 of 7 – SEC Filing
| Item 3. | If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: |
| (a) | ¨ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | ¨ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | ¨ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | ¨ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | ¨ | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | ¨ | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | ¨ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | |
| (h) | ¨ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); | |
| (i) | ¨ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | ¨ | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); | |
| (k) | ¨ | Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution. |
| Item 4. | Ownership. |
| The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page (and the footnotes thereto) for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages set forth in this Schedule 13G/A are calculated based upon an aggregate of 35,034,842 Ordinary Shares outstanding as of April 2, 2017 as reported in the exhibits to the Issuer’s Report of Foreign Private Issuer on Form 6-K filed on April 3, 2017. |
| Item 5. | Ownership of Five Percent or Less of a Class. |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ý |
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 6 of 7 – SEC Filing
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person. |
| Not applicable. |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| Not applicable. |
| Item 8. | Identification and Classification of Members of the Group. |
| Not applicable. |
| Item 9. | Notice of Dissolution of Group. |
| Not applicable. |
| Item 10. | Certification. |
| By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Page 7 of 7 – SEC Filing
SIGNATURE
After reasonable inquiry and to the best of
my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and
correct.
| Date: April 19, 2017 | ||
| SENVEST MANAGEMENT, LLC | ||
| By: | /s/ Bobby Trahanas | |
| Name: | Bobby Trahanas | |
| Title: | Chief Compliance Officer | |
| /s/ Richard Mashaal | ||
| RICHARD MASHAAL | ||
